Ultragenyx Pharmaceutical
RARE
#3817
Rank
HK$25.14 B
Marketcap
HK$260.66
Share price
2.01%
Change (1 day)
-22.83%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: HK$25.14 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of HK$25.14 Billion. This makes Ultragenyx Pharmaceutical the world's 3817th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$25.14 B-19.21%
2024HK$31.12 B1.5%
2023HK$30.66 B20.85%
2022HK$25.37 B-43.22%
2021HK$44.69 B-37.05%
2020HK$70.99 B269.02%
2019HK$19.23 B11.09%
2018HK$17.31 B12.21%
2017HK$15.43 B-30.73%
2016HK$22.27 B-34.1%
2015HK$33.80 B211.04%
2014HK$10.86 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

HK$25.14 Billion
by Nasdaq info icon info icon
HK$25.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
HK$91.40 B 263.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$34.04 B 35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$7.24 B-71.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$3.30 B-86.84%๐Ÿ‡บ๐Ÿ‡ธ USA